2023. Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e01923 | Publicado em: 11/05/2023. Vigilância Sanitária em Debate . 11, (maio 2023), 1–10. DOI:https://doi.org/10.22239/2317-269x.01923.